Heron Therapeutics | HRTX - Процентные расходы





Процентные расходы Изменить Дата
ALKERMES USD 27.55M 1.63M 2026-09
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amarin USD 3K 5K 2024-12
ANI Pharmaceuticals USD 3.06M 580K 2026-09
Anika Therapeutics 183.47M 4.09M 2026-06
Arrowhead Research USD 24.56M 716K 2026-06
Eisai JPY 1.96B 409M 2026-06
GlaxoSmithKline GBP 219M 98M 2026-09
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.41M 1.57M 2026-09
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
Merck USD 525M 46M 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Neurocrine Biosciences USD 300K 2.6M 2026-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 112.4M 108.78M 2026-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Veracyte USD 2K 1000 2023-12
Vertex Pharmaceuticals USD 36M 32.7M 2026-09